Evidence map›Paper›PMID 41165280›Full record

ReviewCurrent opinion in critical care2025

Kidney-organ interactions: recent advances and clinical implications.

Timo Mayerhöfer, Matthieu Legrand, Michael Darmon, Michael Joannidis

Abstract readReview
In one paragraph

Review in Current opinion in critical care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Timo MayerhöferDivision of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.
Matthieu LegrandDepartment of Anesthesia and Peri-Operative Care, Division of Critical Care Medicine, University of California San Francisco, San Francisco, California, USA.
Michael DarmonAP-HP, Medical ICU, Saint-Louis University Hospital.
Michael JoannidisDivision of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.

Funding

The choice of vasopressor to prevent postoperative acute kidney injury after major non-cardiac surgery: a multicenter pragmatic cluster cross-over randomized trial (the VEGA-2 trial)R01DK139484 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SACHIN KHETERPAL, Matthieu Legrand · 2024 to 2026
$2.0M
Identification of sub-phenotypes of severely ill burn patients and risk for secondary sepsis: SEPSISBURNR01GM151494 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Matthieu Legrand · 2023 to 2026
$1.5M
NIDDK NIH HHS R01 DK139484NIGMS NIH HHS R01 GM151494
6 · The paper itself

Abstract

purpose of reviewCritically ill patients often present with multiorgan dysfunction, and the kidney plays a central role in these pathophysiologic interactions. This review aims to provide an up-to-date summary of the most relevant kidney-organ cross-talks in the ICU, including lung, heart, liver, gut, and brain interactions, with emphasis on underlying mechanisms and clinical implications. RECENT

findingsRecent large-scale observational studies and meta-analyses have strengthened the evidence for bidirectional interactions between the kidneys and other organs. In acute respiratory distress syndrome, for example, acute kidney injury contributes significantly to mortality, with inflammation, hemodynamic disturbances, and mechanical ventilation as key elements. Cardiorenal syndromes have been well classified, with venous congestion, immune response and renin-angiotensin-aldosterone system dysregulation identified as the most important drivers. At the core of these organ interactions - including impairments in liver metabolism, intestinal barrier integrity, and brain function - lies systemic inflammation, predominantly mediated by pro-inflammatory cytokines such as interleukin-6 and tumor necrosis factor-alpha, which activate endothelial and immune responses across organ systems and contribute to multiorgan dysfunction. Novel biomarkers and therapeutic interventions are being explored across organ systems. SUMMARY: Organ-kidney cross-talk is a hallmark of critical illness and significantly affects patient outcomes. Understanding these interactions is essential for early diagnosis, risk stratification, and tailored interventions. Integrating knowledge of organ-specific pathophysiology with kidney-centered management strategies holds promise for improving multiorgan recovery and reducing ICU mortality.

Indexed as

Acute Kidney InjuryCritical IllnessKidneyMultiple Organ FailureHumansInflammationIntensive Care Unitsacute kidney injurycardiorenal syndromegut permeabilityhepatorenal syndromelung-kidney interactionneuroinflammation

Identifiers

PMID41165280
PMCPMC13323966

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.